Drugs / Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)
Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00551031 | Oct 2007 → Jun 2008 | influenza | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00551031 ↗ |
| Modality | Vaccine | “trivalent inactivated vaccine (TIV)” NCT00551031 ↗ |